Výsledky vyhledávání - "Inge Marie Obdeijn"

Akademický článek

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

Autor: H. Amarens Geuzinge, Eveline A.M. Heijnsdijk, Inge-Marie Obdeijn, Harry J. de Koning, Madeleine M.A. Tilanus-Linthorst

Publikováno v: Breast, Vol 56, Iss , Pp 1-6 (2021)

Background: Several studies have investigated MRI breast cancer screening in women at increased risk, but little is known about their preferences. In this study, experiences, expectations and preferences for MRI and mammography were evaluated among w

Externí odkaz: https://doaj.org/article/4387c7c2092e492eb4afb7f6524969bf

Zobrazit plný text záznamu

Screening and diagnostic breast MRI: how do they impact surgical treatment? Insights from the MIPA study

Autor: Andrea Cozzi, Giovanni Di Leo, Nehmat Houssami, Fiona J. Gilbert, Thomas H. Helbich, Marina Álvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese, Julia Camps Herrero, Francesco Cartia, Enrico Cassano, Paola Clauser, Marcos F. de Lima Docema, Catherine Depretto, Valeria Dominelli, Gábor Forrai, Rossano Girometti, Steven E. Harms, Sarah Hilborne, Raffaele Ienzi, Marc B. I. Lobbes, Claudio Losio, Ritse M. Mann, Stefania Montemezzi, Inge-Marie Obdeijn, Umit A. Ozcan, Federica Pediconi, Katja Pinker, Heike Preibsch, José L. Raya Povedano, Carolina Rossi Saccarelli, Daniela Sacchetto, Gianfranco P. Scaperrotta, Margrethe Schlooz, Botond K. Szabó, Donna B. Taylor, Özden S. Ulus, Mireille Van Goethem, Jeroen Veltman, Stefanie Weigel, Evelyn Wenkel, Chiara Zuiani, Francesco Sardanelli

Publikováno v: European Radiology. Springer-Verlag
European radiology
European Radiology

Objectives To report mastectomy and reoperation rates in women who had breast MRI for screening (S-MRI subgroup) or diagnostic (D-MRI subgroup) purposes, using multivariable analysis for investigating the role of MRI referral/nonreferral and other co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d119021ded1034438cdbdaefc425cadc
https://doi.org/10.1007/s00330-023-09600-5

Zobrazit plný text záznamu

Abstract GS4-07: Costs and effects in the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc

Autor: Martijne van 't Riet, Emiel J. Th. Rutgers, Inge-Marie Obdeijn, Jelle Wesseling, Harry J. de Koning, S. Saadatmand, Margreet G. E. M. Ausems, Jan C. Oosterwijk, Ernest J. T. Luiten, Ritse M. Mann, Maartje J. Hooning, Madeleine M. A. Tilanus-Linthorst, Marc B. I. Lobbes, Diderick B W de Roy van Zuidewijn, Robert A.E.M. Tollenaar, Eveline A.M. Heijnsdijk, H Amarens Geuzinge, Ingeborg Mares-Engelberts

Publikováno v: Cancer Research. 80:GS4-07

Background: The large favorable stage shift, that MRI screening causes as compared with mammography has been published recently in Lancet Oncology as well as the disadvantage of more false-positive results with MRI. Here we want to present the first

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5eb90e0a07a1ce0910ef9af8d50fe836
https://doi.org/10.1158/1538-7445.sabcs19-gs4-07

Zobrazit plný text záznamu

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? – A cost-effectiveness analysis

Autor: Xuan-Anh Phi, Marcel J. W. Greuter, Nehmat Houssami, Inge-Marie Obdeijn, Talitha L Feenstra, Jan C. Oosterwijk, Geertruida H. de Bock

Publikováno v: The Breast, 45, 82-88. Churchill Livingstone
Breast, 45, 82-88. Churchill Livingstone
The Breast

OBJECTIVES: This study aimed to investigate the cost-effectiveness of intensified breast cancer (BC) screening for women with a BRCA1/2 mutation aged 60-74. Simulated strategies were: (0) annual mammography as reference, (1) alternating annual mammog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da9eb90d93c25b5d7473519423c4e22
https://doi.org/10.1016/j.breast.2019.03.004

Zobrazit plný text záznamu

Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA)

Autor: Mireille Van Goethem, Federica Pediconi, Catherine Depretto, Corinne Balleyguier, Francesco Cartia, Stefania Montemezzi, Rubina M. Trimboli, Ritse M. Mann, Giovanni Di Leo, Inge Marie Obdeijn, Marc B. I. Lobbes, Umit Aksoy Ozcan, Fiona J. Gilbert, Paola Clauser, Raffaele Ienzi, Heike Preibsch, Massimo Calabrese, Ozden S. Ulus, José Luis Raya Povedano, Andrea Cozzi, Danubia A. de Andrade, Sarah Hilborne, Katja Pinker, Julia Camps Herrero, Jeroen Veltman, Steven E. Harms, Marcos F. de Lima Docema, Chiara Zuiani, Evelyn Wenkel, Peter Bult, Stefanie Weigel, Enrico Cassano, Gianfranco Scaperrotta, Donna Taylor, Margrethe S. Schlooz, Massimo Bazzocchi, Claudio Losio, Rossano Girometti, Thomas H. Helbich, Gabor Forrai, Simone Schiaffino, Daniela Sacchetto, Botond K. Szabó, Marina Benito, Nehmat Houssami, Valeria Dominelli, Francesco Sardanelli

Publikováno v: European Radiology
European Radiology, 32, 1611-1623
European Radiology, 32(3), 1611-1623. Springer-Verlag
European radiology
European Radiology, 32, 3, pp. 1611-1623
European Radiology, 32(3), 1611-1623. Springer, Cham

Objectives Preoperative breast magnetic resonance imaging (MRI) can inform surgical planning but might cause overtreatment by increasing the mastectomy rate. The Multicenter International Prospective Analysis (MIPA) study investigated this controvers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9ed1196657d036248f44ccd1f27f096
https://hdl.handle.net/2123/30249

Zobrazit plný text záznamu

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study

Publikováno v: European Radiology, 30(10), 5427-5436. Springer, Cham
European radiology
European Radiology, 30(10), 5427-5436. Springer-Verlag
European Radiology, 30, 5427-5436
European Radiology, 30, 10, pp. 5427-5436
European Radiology
EUROPEAN RADIOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Contains fulltext : 225795.pdf (Publisher’s version ) (Closed access) Despite its high diagnostic performance, the use of breast MRI in the preoperative setting is controversial. It has the potential for personalized surgical management in breast c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da1c4ccddbbf347ea786035e92706ce
https://www.repository.cam.ac.uk/handle/1810/302407

Zobrazit plný text záznamu

Multidisciplinary breast cancer guideline in the Netherlands: Modular revisions aiming for improved personalized breast cancer care

Autor: J. Verloop, Inge-Marie Obdeijn, Luc J. A. Strobbe, Sabine Siesling, Carolien H. Smorenburg, Aafke H. Honkoop, T. Smit-Hoeksma, D. Hairwassers, T. van Vegchel, M.J.C. van der Sangen, John H. Maduro, J. van Middelkoop-van Hoeve, Liesbeth J. Boersma

Publikováno v: None
European Journal of Cancer, 138. Elsevier Ltd.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dedba8e7ef71400373fabf151eaa14f
https://hdl.handle.net/11370/bb1acd67-fcc0-4c1f-ad94-9807503aa58c

Zobrazit plný text záznamu

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

Publikováno v: JAMA Oncology, 6(9), 1381-1389. AMER MEDICAL ASSOC
JAMA oncology, 6(9), 1381-1389. AMER MEDICAL ASSOC
JAMA Oncology, 6(9), 1381-1389. American Medical Association
Jama Oncology, 6, 1381-1389
JAMA oncology, 6(9), 1381-1389. American Medical Association
Jama Oncology, 6, 9, pp. 1381-1389

Importance For women with a 20% or more familial risk of breast cancer without a known BRCA1/2 (BRCA1, OMIM; and BRCA2, OMIM) or TP53 (OMIM) variant, screening guidelines vary substantially, and cost-effectiveness analyses are scarce.Objective To ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa76efd63055fd3011ace7cfe0eee91
http://hdl.handle.net/1887/3185317

Zobrazit plný text záznamu

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

Autor: Eleonora M. C. Voormolen, Ritse M. Mann, Inge-Marie Obdeijn, Maartje J. Hooning, Geertruida H. de Bock, Marc B. I. Lobbes, Carolien H.M. van Deurzen, Claudette E. Loo

Publikováno v: Breast Cancer Research and Treatment, 181, 581-588
Breast Cancer Research and Treatment, 181(3), 581-588. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 181(3), 581-588. SPRINGER
Breast Cancer Research and Treatment, 181, 3, pp. 581-588
Breast Cancer Research and Treatment, 181(3), 581-588. Springer, Cham

Purpose BRCA2 mutation carriers are offered annual breast screening with MRI and mammography. The aim of this study was to investigate the supplemental value of mammographic screening over MRI screening alone. Methods In this multicenter study, prove

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed01d4cde2df44c06cd3677b577be7d7
http://hdl.handle.net/2066/220728

Zobrazit plný text záznamu

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Autor: A Inge-Marie Obdeijn, Matti A. Rookus, Jakob de Vries, Hester S. A. Oldenburg, Bernadette A M Heemskerk-Gerritsen, Linetta B. Koppert, C. Marleen Kets, Margriet Collée, Agnes Jager, Maartje J. Hooning, Peter Devilee, Marinus J. Blok, Caroline Seynaeve, Klaartje van Engelen, Denise J Jenner, Margreet G. E. M. Ausems, Hanne Meijers-Heijboer, Christi J. van Asperen

Publikováno v: Breast Cancer Research and Treatment, 177(3), 723-733. SPRINGER
Breast Cancer Research and Treatment, 177, 3, pp. 723-733
Breast Cancer Research and Treatment, 177, 723-733
Breast cancer research and treatment, 177(3), 723-733. Springer New York
Breast Cancer Research and Treatment, 177(3), 723-733. Springer, Cham
Breast Cancer Research and Treatment, 177(3), 723-733. Springer New York
Breast Cancer Research and Treatment
Heemskerk-Gerritsen, B A M, Jager, A, Koppert, L B, Obdeijn, A I-M, Collée, M, Meijers-Heijboer, H E J, Jenner, D J, Oldenburg, H S A, van Engelen, K, de Vries, J, van Asperen, C J, Devilee, P, Blok, M J, Kets, C M, Ausems, M G E M, Seynaeve, C, Rookus, M A & Hooning, M J 2019, ' Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers ', Breast Cancer Research and Treatment, vol. 177, no. 3, pp. 723-733 . https://doi.org/10.1007/s10549-019-05345-2

Background In healthy BRCA1/2 mutation carriers, bilateral risk-reducing mastectomy (BRRM) strongly reduces the risk of developing breast cancer (BC); however, no clear survival benefit of BRRM over BC surveillance has been reported yet. Methods In t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bbc76d65e793fc4aaf5eb2be755a9b5
https://research.rug.nl/en/publications/ef2785ef-b887-4494-bed5-895c0f5bedc0

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání